159 related articles for article (PubMed ID: 25566410)
1. Association Between Microbial Bioburden and Healing Outcomes in Venous Leg Ulcers: A Review of the Evidence.
Tuttle MS
Adv Wound Care (New Rochelle); 2015 Jan; 4(1):1-11. PubMed ID: 25566410
[No Abstract] [Full Text] [Related]
2. Use of 16S rRNA sequencing and quantitative PCR to correlate venous leg ulcer bacterial bioburden dynamics with wound expansion, antibiotic therapy, and healing.
Sprockett DD; Ammons CG; Tuttle MS
Wound Repair Regen; 2015 Sep; 23(5):765-71. PubMed ID: 25902876
[TBL] [Abstract][Full Text] [Related]
3. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration.
O'Meara S; Cullum N; Majid M; Sheldon T
Health Technol Assess; 2000; 4(21):1-237. PubMed ID: 11074391
[TBL] [Abstract][Full Text] [Related]
4. Next-Generation Sequencing: A Review of Technologies and Tools for Wound Microbiome Research.
Hodkinson BP; Grice EA
Adv Wound Care (New Rochelle); 2015 Jan; 4(1):50-58. PubMed ID: 25566414
[No Abstract] [Full Text] [Related]
5. S100A8/A9 is an important host defence mediator in neuropathic foot ulcers in patients with type 2 diabetes mellitus.
Trøstrup H; Holstein P; Christophersen L; Jørgensen B; Karlsmark T; Høiby N; Moser C; Ågren MS
Arch Dermatol Res; 2016 Jul; 308(5):347-55. PubMed ID: 27084691
[TBL] [Abstract][Full Text] [Related]
6. The Wound Microbiome: Modern Approaches to Examining the Role of Microorganisms in Impaired Chronic Wound Healing.
Misic AM; Gardner SE; Grice EA
Adv Wound Care (New Rochelle); 2014 Jul; 3(7):502-510. PubMed ID: 25032070
[No Abstract] [Full Text] [Related]
7. The real cost of treating venous ulcers in a contemporary vascular practice.
Ma H; O'Donnell TF; Rosen NA; Iafrati MD
J Vasc Surg Venous Lymphat Disord; 2014 Oct; 2(4):355-61. PubMed ID: 26993537
[TBL] [Abstract][Full Text] [Related]
8. A comparison of an antimicrobial wound cleanser to normal saline in reduction of bioburden and its effect on wound healing.
Lindfors J
Ostomy Wound Manage; 2004 Aug; 50(8):28-41. PubMed ID: 15356367
[TBL] [Abstract][Full Text] [Related]
9. Bacteriology, inflammation, and healing: a study of nanocrystalline silver dressings in chronic venous leg ulcers.
Sibbald RG; Contreras-Ruiz J; Coutts P; Fierheller M; Rothman A; Woo K
Adv Skin Wound Care; 2007 Oct; 20(10):549-58. PubMed ID: 17906429
[TBL] [Abstract][Full Text] [Related]
10. Silver dressings improve diabetic wound healing without reducing bioburden.
Finley PJ; Huckfeldt RE; Walker KD; Shornick LP
Wounds; 2013 Oct; 25(10):293-301. PubMed ID: 25867520
[TBL] [Abstract][Full Text] [Related]
11. Biophysical Technologies for Management of Wound Bioburden.
Korzendorfer H; Hettrick H
Adv Wound Care (New Rochelle); 2014 Dec; 3(12):733-741. PubMed ID: 25493207
[No Abstract] [Full Text] [Related]
12. Fungi in the Wound Microbiome.
Kalan L; Grice EA
Adv Wound Care (New Rochelle); 2018 Jul; 7(7):247-255. PubMed ID: 29984114
[No Abstract] [Full Text] [Related]
13. The influence of patient and wound variables on healing of venous leg ulcers in a randomized controlled trial of growth-arrested allogeneic keratinocytes and fibroblasts.
Lantis JC; Marston WA; Farber A; Kirsner RS; Zhang Y; Lee TD; Cargill DI; Slade HB
J Vasc Surg; 2013 Aug; 58(2):433-9. PubMed ID: 23588112
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobials and Non-Healing Wounds. Evidence, controversies and suggestions-key messages.
Gottrup F; Apelqvist J; Bjarnsholt T; Cooper R; Moore Z; Peters EJ; Probst S
J Wound Care; 2014 Oct; 23(10):477-8, 480, 482. PubMed ID: 25296348
[TBL] [Abstract][Full Text] [Related]
15. Chronic venous disease and venous leg ulcers: An evidence-based update.
Kelechi TJ; Johnson JJ; Yates S
J Vasc Nurs; 2015 Jun; 33(2):36-46. PubMed ID: 26025146
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes and cost-effectiveness of three alternative compression systems used in the management of venous leg ulcers.
Guest JF; Gerrish A; Ayoub N; Vowden K; Vowden P
J Wound Care; 2015 Jul; 24(7):300, 302-5, 307-8, passim. PubMed ID: 26198552
[TBL] [Abstract][Full Text] [Related]
17. Bioburden-responsive antimicrobial PLGA ultrafine fibers for wound healing.
Said SS; El-Halfawy OM; El-Gowelli HM; Aloufy AK; Boraei NA; El-Khordagui LK
Eur J Pharm Biopharm; 2012 Jan; 80(1):85-94. PubMed ID: 21924354
[TBL] [Abstract][Full Text] [Related]
18. Relative cost-effectiveness of a skin protectant in managing venous leg ulcers in the UK.
Guest JF; Taylor RR; Vowden K; Vowden P
J Wound Care; 2012 Aug; 21(8):389-94, 396-8. PubMed ID: 22885312
[TBL] [Abstract][Full Text] [Related]
19. Healing and healing rates of chronic wounds in the age of molecular pathogen diagnostics.
Wolcott RD; Cox SB; Dowd SE
J Wound Care; 2010 Jul; 19(7):272-8, 280-1. PubMed ID: 20616768
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and treatment of diabetic foot infections.
Lipsky BA; Berendt AR; Deery HG; Embil JM; Joseph WS; Karchmer AW; LeFrock JL; Lew DP; Mader JT; Norden C; Tan JS;
Plast Reconstr Surg; 2006 Jun; 117(7 Suppl):212S-238S. PubMed ID: 16799390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
